These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5881 related articles for article (PubMed ID: 4009515)

  • 1. The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma.
    Temoshok L; Heller BW; Sagebiel RW; Blois MS; Sweet DM; DiClemente RJ; Gold ML
    J Psychosom Res; 1985; 29(2):139-53. PubMed ID: 4009515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophysiology and tumor-host response.
    Temoshok L
    Soc Sci Med; 1985; 20(8):833-40. PubMed ID: 4001992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma.
    Temoshok L; DiClemente RJ; Sweet DM; Blois MS; Sagebiel RW
    Cancer; 1984 Dec; 54(12):3048-53. PubMed ID: 6498779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychosocial aspects of malignant melanoma].
    Denz MD
    Ther Umsch; 1999 Jun; 56(6):342-7. PubMed ID: 10420819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Melanoma patients: psychosocial stress, coping with illness and social support. A systematic review].
    Söllner W; Zschocke I; Augustin M
    Psychother Psychosom Med Psychol; 1998; 48(9-10):338-48. PubMed ID: 9785963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient knowledge, awareness, and delay in seeking medical attention for malignant melanoma.
    Oliveria SA; Christos PJ; Halpern AC; Fine JA; Barnhill RL; Berwick M
    J Clin Epidemiol; 1999 Nov; 52(11):1111-6. PubMed ID: 10527006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline psychosocial predictors of survival in localized melanoma.
    Lehto US; Ojanen M; Dyba T; Aromaa A; Kellokumpu-Lehtinen P
    J Psychosom Res; 2007 Jul; 63(1):9-15. PubMed ID: 17586333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of psychological variables in a group of melanoma patients. An Israeli sample.
    Baider L; Perry S; Sison A; Holland J; Uziely B; DeNour AK
    Psychosomatics; 1997; 38(1):45-53. PubMed ID: 8997116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and psychosocial factors related to delay behavior in patients with cutaneous malignant melanoma.
    Temoshok L; DiClemente RJ; Sweet DM; Blois MS; Sagebiel RW
    Prog Clin Biol Res; 1984; 156():169-79. PubMed ID: 6473424
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychosocial aspects of melanoma.
    Gibertini M; Reintgen DS; Baile WF
    Ann Plast Surg; 1992 Jan; 28(1):17-21. PubMed ID: 1642400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer prognosis, psychosocial stress and attitude of melanoma patients to supportive psychotherapy].
    Söllner W; Mairinger G; Zingg-Schir M; Fritsch P
    Hautarzt; 1996 Mar; 47(3):200-5. PubMed ID: 8647703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical correlates of Breslow thickness of malignant melanoma.
    Osborne JE; Hutchinson PE
    Br J Dermatol; 2001 Mar; 144(3):476-83. PubMed ID: 11260002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repressive coping reactions in patients with malignant melanoma as compared to cardiovascular disease patients.
    Kneier AW; Temoshok L
    J Psychosom Res; 1984; 28(2):145-55. PubMed ID: 6737328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological status and coping with illness in patients with malignant melanoma.
    Vurnek M; Buljan M; Situm M
    Coll Antropol; 2007 Jan; 31 Suppl 1():53-6. PubMed ID: 17469751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with a high tumour thickness in patients with melanoma.
    Baumert J; Plewig G; Volkenandt M; Schmid-Wendtner MH
    Br J Dermatol; 2007 May; 156(5):938-44. PubMed ID: 17381454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative assessment of psychosocial impact, coping and adjustment in high-risk melanoma patients and caregivers.
    Tan JD; Butow PN; Boyle FM; Saw RP; O'Reilly AJ
    Melanoma Res; 2014 Jun; 24(3):252-60. PubMed ID: 24584097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological responses to malignant melanoma. An investigation of traumatic stress reactions to life-threatening illness.
    Kelly B; Raphael B; Smithers M; Swanson C; Reid C; McLeod R; Thomson D; Walpole E
    Gen Hosp Psychiatry; 1995 Mar; 17(2):126-34. PubMed ID: 7789783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
    Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
    J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of religious and spiritual beliefs in coping with malignant melanoma: an Israeli sample.
    Baider L; Russak SM; Perry S; Kash K; Gronert M; Fox B; Holland J; Kaplan-Denour A
    Psychooncology; 1999; 8(1):27-35. PubMed ID: 10202780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosomatic services for melanoma patients in tertiary care.
    Körner A; Fritzsche K
    Int J Dermatol; 2012 Sep; 51(9):1060-7. PubMed ID: 22909359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 295.